A Meeting Place for Patients, Caregivers and Patient Associations
General information
This section provides information for patients, users, caregivers, patient groups and associations as drug and technological products are being evaluated. You'll find:
- Why and how to contribute
- Consultation process and methods
- Commenting on a drug
- Publications
If you have any questions about the consultation process for drugs evaluated for listing, please contact our team at the following e-mail address: plan.commentaires.inscription@inesss.qc.ca.
N'hésitez pas à consulter cette page dédiée à la consultation patient.
Vous souhaitez nous partager des commentaires, vous pouvez le faire à l’aide de ce sondage anonyme.